Cipla completes Phase-3 clinical study for generic version of GSK Advair Diskus Medical Dialogues Bureau5 April 2020 2:41 PM ISTMumbai: Cipla Limited has announced the successful completion of the Phase-3 clinical end-point study for fluticasone propionate and salmeterol...
EMA accepts GSK filing for Trelegy Ellipta use in adults with asthma Medical Dialogues Bureau4 March 2020 10:15 AM ISTonce-daily single inhaler triple therapy available for asthma and COPD if approved
Sub-committee to align Drugs And Cosmetics, Magical Remedies Act to regulate Medical Advertisements: CDSCO Committee Farhat Nasim2 Oct 2019 11:48 AM ISTNew Delhi: The Drug Consultative Committee (DCC), functional under the apex drug regulatory body, Central Drug Standard Control Organisation (CDSCO)...
Sanofi revival depends on outsider with nose for big drugs: Report Medical Dialogues Bureau3 Sept 2019 8:58 AM ISTDefining Sanofi's ambitions in the cutting-edge field of gene therapies and figuring out whether to hold on to consumer health brands are among other...
Lupin unveils generic Imatinib Mesylate tablets to treat types of cancer Medical Dialogues Bureau10 July 2019 10:00 AM ISTLupin's Imatinib Mesylate Tablets, 100mg (base) and 400mg (base), is the generic version of Novartis Pharmaceuticals Corporation's (Novartis) Gleevec...
Cipla moves against NPPA for price fixation of asthma drugs; DOP junks plea Farhat Nasim16 Jun 2019 11:44 AM ISTNew Delhi: Mumbai-based drugmaker, Cipla Limited's review petition against the Government regulatory agency, National Pharmaceutical Pricing Authority...
GSK Nucala wins USFDA approval for two new self-administration options Farhat Nasim9 Jun 2019 10:00 AM ISTNucala is the first anti-IL5 biologic to be licensed in the US for at-home administration, and the first respiratory biologic to be approved for...
Cipla, Pulmatrix join hands to co-develop Pulmazole for treating asthma Garima16 April 2019 9:40 AM ISTPulmazole an inhaled iSPERSE formulation of the antifungal drug itraconazole for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in...
Cipla launches respiratory inhalation therapy product Niveoli in India Farhat Nasim12 April 2019 11:41 AM ISTNew Delhi: Drug major Cipla Friday announced the launch of its proprietary respiratory inhalation therapy product 'Niveoli' in India. Niveoli is used...
GSK gets USFDA nod for HIV-1 drug branded as Dovato Farhat Nasim9 April 2019 9:20 AM ISTGSK already has two-drug regimen Juluca on the market, but only for the smaller market of HIV patients that have received prior treatment. Dovato is...
Cipla signs over Rs 152 crore pact with Pulmatrix for new asthma drug Pulmazole Garima2 April 2019 9:45 AM ISTThe agreement has been signed between the company's wholly-owned subsidiary in the US, Cipla Technologies LLC with Pulmatrix Inc for investment in...
Mylan launches Advair generic at 70 percent discount in US Farhat Nasim14 Feb 2019 9:15 AM ISTThe treatment, the first generic of Advair, is approved in three doses and will be priced between $93.71 and $153.14, the company said.U.S: Mylan NV...
